Similar Articles
311 Liver transplantation for combined hepatocellular carcinoma and cholangiocarcinoma: A multicenter study
312 Serum resistin and the risk for hepatocellular carcinoma in diabetic patients
313 Radiomics model based on contrast-enhanced computed tomography to predict early recurrence in patients with hepatocellular carcinoma after radical resection
314 CK5/6-positive, P63-positive lymphoepithelioma-like hepatocellular carcinoma: A case report and literature review
315 Effect of lifestyle modification on hepatocellular carcinoma incidence and mortality among patients with chronic hepatitis B
316 Stereotactic body radiotherapy combined with sintilimab in patients with recurrent or oligometastatic hepatocellular carcinoma: A phase II clinical trial
317 Massive bleeding from a gastric artery pseudoaneurysm in hepatocellular carcinoma treated with atezolizumab plus bevacizumab: A case report
318 Correction: Propensity-matched analysis of patients with intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma and hepatocellular carcinoma undergoing a liver transplant
319 Transcription factor glucocorticoid modulatory element-binding protein 1 promotes hepatocellular carcinoma progression by activating Yes-associate protein 1
320 Role of p53 suppression in the pathogenesis of hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA